Table 2.
Patient characteristics (PICU group, 19 patients)
| Age (months), median (Q1–Q3) | 13.7 (1.5–34) |
| Weight (kg), median (Q1–Q3) | 11 (3.8–17.3) |
| Sex, male (%) | 12 (63.2%) |
| Comorbidity, n (%) | |
| Prematurity | 6 (31.6%) |
| Previous episode of invasive ventilation (within 7 days of intubation) | 3 (15.8%) |
| Reason for PICU admission, n (%) | |
| Neurological (traumatic brain injury) | 1 (5.3%) |
| Neurological (excluding traumatic brain injury) | 4 (21.1%) |
| Respiratory-upper airway | 4 (21.1%) |
| Respiratory-lower airway/pulmonary | 7 (36.8%) |
| Sepsis/shock | 1 (5.3%) |
| Other | 2 (10.5%) |
| Reason for intubation, n (%) | |
| Neurological | 4 (21.1%) |
| Apnea | 3 (15.8%) |
| Respiratory-upper airway | 4 (21.1%) |
| Respiratory-lower airway/pulmonary | 6 (31.6%) |
| Hemodynamics | 1 (5.3%) |
| Procedure | 1 (5.3%) |
| Drugs used during study period, n (%) | |
| Paralysis (excluding for intubation) | 5 (26.3%) |
| Corticosteroids | 8 (42.1%) |
| Inotropes/vasodilators | 5 (26.3%) |
| Spontaneous mode used during MV episode (NAVA/PSV), n (%) | 14 (73.7%) |
| Number of measurements, median (Q1–Q3) | 3 (2.5–4) |
| PICU outcomes | |
| Duration of MV (hours), median (Q1–Q3) | 63.9 (50.4–77.4) |
| Reintubation within 24 h of extubation, n (%) | 0 (0%) |
| Rescue NIV for more than 72 h post-extubation, n (%) | 2 (10.5%) |
| PICU length of stay (days), median (Q1–Q3) | 5.3 (4–8.8) |
| Died during PICU admission, n (%) | 0 (0%) |
PICU pediatric intensive care unit, Q1–Q3 first and third quartiles, NAVA neurally adjusted ventilatory assist, PSV pressure-support ventilation, MV mechanical ventilation, NIV non-invasive ventilation